Asked by: Simon Burns (Conservative - Chelmsford)
Question to the Department for Transport:
To ask the Secretary of State for Transport, if he will publish punctuality figures for the Greater Anglia service between Chelmsford and London Liverpool Street for each of the last three years.
Answered by Claire Perry
The Department does not hold punctuality figures at the level of detail requested. This is an operational matter for Network Rail.
Asked by: Simon Burns (Conservative - Chelmsford)
Question to the Department for Transport:
To ask the Secretary of State for Transport, if he will publish punctuality figures for the Greater Anglia service between Chelmsford and London Liverpool Street for each of the last six months.
Answered by Claire Perry
The Department does not hold punctuality figures at the level of detail requested. This is an operational matter for Network Rail.
Asked by: Simon Burns (Conservative - Chelmsford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, pursuant to the Answer of 11 November 2014 to Question 213785, what the terms of reference are for the Pneumococcal sub-committee's review; if he will place in the Library a copy of the terms of reference of that review; and if he will make a statement.
Answered by Jane Ellison
The terms of reference for the pneumococcal subcommittee of the Joint Committee on Vaccination and Immunisation (JCVI) will be agreed at its first meeting, to be held in spring 2015.
Once agreed, the terms of reference will be published in the minutes of the sub-committee meeting and available for public access on the gov.uk website.
Asked by: Simon Burns (Conservative - Chelmsford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, with reference to paragraph 54 of the minutes of the meeting of 4 June 2014 of the Joint Committee on Vaccination and Immunisation, over what period of time Public Health England intends to revise the cost effectiveness model of pneumococcal polysaccharide vaccine to include the latest epidemiological data on pneumococcal disease in the UK; and if he will make a statement.
Answered by Jane Ellison
Public Health England (PHE) will review modelling undertaken on the impact and cost-effectiveness of the Pneumococcal Polysaccharide Vaccine (PPV) programme in over-65 year olds using the latest epidemiological data on invasive pneumococcal disease in the United Kingdom. PHE will report its findings to the Pneumococcal Sub-committee of the Joint Committee on Vaccination and Immunisation (JCVI). It is anticipated that the Pneumococcal Sub-committee will meet for the first time in spring 2015.
At this meeting of the Pneumococcal Sub-committee members will review information including epidemiological data and PHE’s report on PPV impact and cost-effectiveness. Should all the required data be available to the Sub-committee, and subject to the requirement for additional meetings and, if required, additional modelling, it is anticipated that it will report to the JCVI main committee. The JCVI will form advice at the October 2015 meeting. The minutes of this meeting will be published in winter 2015.
Asked by: Simon Burns (Conservative - Chelmsford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, with reference to paragraph 49 of the minutes of the meeting of 4 June 2014 of the Joint Committee on Vaccination and Immunisation (JCVI), when his Department indicated to the JCVI that it would like the JCVI to confirm or revise its conclusions regarding the pneumococcal conjugate vaccine of choice for the UK; how his Department indicated its wish to the JCVI; whether he is satisfied that the JCVI has complied with his Department's request; and if he will make a statement.
Answered by Jane Ellison
The request from the Department to the Joint Committee on Vaccination and Immunisation (JCVI) regarding the use of pneumococcal conjugate vaccine (PCV) in the United Kingdom was conveyed by Departmental officials via the JCVI secretariat within Public Health England in early 2014.
At its meeting on 4 June 2014, the minutes of which are available on GOV.UK, the JCVI concluded that PCV13 should remain the pneumococcal conjugate vaccine of choice for the United Kingdom at this time. We have accepted this advice.
Asked by: Simon Burns (Conservative - Chelmsford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, how much has been paid to Virgin Care to run the North Chelmsford NHS Healthcare Centre in Sainsburys in Springfield, Chelmsford in each year since it opened.
Answered by Dan Poulter
The information requested is not centrally held.
Asked by: Simon Burns (Conservative - Chelmsford)
Question to the Department for Transport:
To ask the Secretary of State for Transport, how many (a) deaths and (b) injuries occurred as a result of road traffic accidents on the A12 from Junction 28 of the M25 to Ipswich in each of the last three years.
Answered by John Hayes
The 2011, 2012 and 2013 statistics for fatal, serious and slight injuries occurring as a result of road traffic accidents on the A12 from its junction with the M25 (junction 28) to its junction with the A14 (junction 55, near Ipswich) are set out in the table below:
| ||||
| Fatal | Serious | Slight | |
2011 | 5 | 32 | 201 | |
2012 | 2 | 18 | 178 | |
2013 | 3 | 23 | 185 |
Asked by: Simon Burns (Conservative - Chelmsford)
Question to the Department for Transport:
To ask the Secretary of State for Transport, what steps he is taking to improve road safety on the A12 from Junction 28 of the M25 to Ipswich.
Answered by John Hayes
The Highways Agency takes road safety very seriously and they monitor the safety of the A12 trunk road as well as all other routes on the strategic road network.
The Agency is committed to delivering four safety improvement schemes on the A12 this financial year valued at approximately £2.1million. Two of these are being delivered through the national Pinch Point Programme.
Tackling congestion and improving the performance of the strategic road network is also a key factor to improving safety. The Highways Agency is continuing to develop Stage 2 of the East of England Route Strategy, which includes the A12, and is due to be completed by spring 2015. Following completion of evidence gathering Stage 1 in April, the Agency is now undertaking a series of studies based on that evidence which will form outline business cases for tackling congestion, improving performance and ultimately improving safety on the strategic road network.
Asked by: Simon Burns (Conservative - Chelmsford)
Question to the Department for Transport:
To ask the Secretary of State for Transport, how many road traffic accidents there were on the A12 from Junction 28 of the M25 to Ipswich in each of the last three years.
Answered by John Hayes
The 2011, 2012 and 2013 statistics for road traffic accidents on the A12 from its junction with the M25 (junction 28) to its junction with the A14 (junction 55, near Ipswich) are set out in the table below:
Year | Collisions |
2011 | 150 |
2012 | 141 |
2013 | 154 |
There is no requirement for accidents resulting in damage only to be reported to the police and therefore this data is not included.
Asked by: Simon Burns (Conservative - Chelmsford)
Question
To ask the hon. Member for Caithness, Sutherland and Easter Ross representing the House of Commons Commission, pursuant to the Answer of 5 September 2014 to Question 207883, if the Commission will make available to the right hon. Member for Chelmsford all the records of all the discussions of the panel considering the appointment of the new Clerk of the House and Chief Executive with the personal data of the applicants redacted.
Answered by Viscount Thurso
Applicants for the role of Clerk of the House and Chief Executive applied in confidence. Records relating to the recruitment process constitute the personal data of the applicants. It would still be possible to identify personal information about individuals following the redaction of names and other personal data from records of the panel discussion. It is not the Commission’s practice to disclose confidential personal information of this nature.